Artivion, Inc.
Artivion, Inc., formerly known as Aortech International, is a leading medical technology company headquartered in the United States. Founded in 2000, Artivion has established itself in the cardiovascular industry, focusing on innovative solutions for cardiac and vascular surgery. The company is renowned for its advanced bioengineered products, including the Aorfix™ stent graft, which offers unique features for treating aortic aneurysms. With a strong presence in North America and expanding operations in Europe and Asia, Artivion is committed to enhancing patient outcomes through its cutting-edge technologies. The company has achieved significant milestones, including regulatory approvals and partnerships that bolster its market position. Artivion continues to be recognised for its dedication to innovation and quality in the medical device sector, making it a trusted name among healthcare professionals worldwide.
DitchCarbon Score
How does Artivion, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Artivion, Inc.'s score of 25 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Artivion, Inc.'s reported carbon emissions
In 2021, Artivion, Inc. reported total carbon emissions of approximately 6,116,000 kg CO2e. This figure includes 5,051,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 558,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Additionally, the company recorded 1,051,000 kg CO2e in Scope 3 emissions, which encompass all other indirect emissions that occur in the value chain. As of the latest data, Artivion has not established specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of documented reduction targets suggests that the company may still be in the early stages of formalising its climate commitments. Artivion's emissions data is not cascaded from any parent or related organisation, indicating that the reported figures are solely from its own operations. The company operates within the medical technology sector, which is increasingly focusing on sustainability and carbon footprint reduction, highlighting the importance of establishing clear climate strategies in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 5,051,000 |
| Scope 2 | 558,000 |
| Scope 3 | 1,051,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Artivion, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
